<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37654570</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2392</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in endocrinology</Title><ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Editorial: The gut-pancreas axis in type 1 diabetes - a focus on environmental factors.</ArticleTitle><Pagination><StartPage>1270297</StartPage><MedlinePgn>1270297</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1270297</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2023.1270297</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fløyel</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Type 1 Diabetes Research, Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funda</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Microbiology of the Czech Academy of Sciences, v.v.i., Prague, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodero</LastName><ForeName>Veronica I</ForeName><Initials>VI</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Organic Chemistry III, Bielefeld University, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haupt-Jorgensen</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Bartholin Institute, Department of Pathology, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Endocrinol (Lausanne)</MedlineTA><NlmUniqueID>101555782</NlmUniqueID><ISSNLinking>1664-2392</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Editorial on the Research Topic The gut-pancreas axis in type 1 diabetes – a focus on environmental factors</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NOD mouse</Keyword><Keyword MajorTopicYN="N">beta-cell stress</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">environmental factors</Keyword><Keyword MajorTopicYN="N">gluten-free diet</Keyword><Keyword MajorTopicYN="N">gut-pancreas axis</Keyword><Keyword MajorTopicYN="N">intestinal permeability</Keyword><Keyword MajorTopicYN="N">type 1 diabetes</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>1</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37654570</ArticleId><ArticleId IdType="pmc">PMC10466039</ArticleId><ArticleId IdType="doi">10.3389/fendo.2023.1270297</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gillespie KM, Bain SC, Barnett AH, Bingley PJ, Christie MR, Gill GV, et al. . The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet (2004) 364:1699–700. doi: 10.1016/S0140-6736(04)17357-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(04)17357-1</ArticleId><ArticleId IdType="pubmed">15530631</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman V, Pruhova S, Kulich M, Kolouskova S, Vosahlo J, Romanova M, et al. . Gluten-free diet in children with recent-onset type 1 diabetes: A 12-month intervention trial. Diabetes Obes Metab (2020) 22:866–72. doi: 10.1111/dom.13974</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.13974</ArticleId><ArticleId IdType="pubmed">31984648</ArticleId></ArticleIdList></Reference><Reference><Citation>Carre A, Vecchio F, Flodstrom-Tullberg M, You S, Mallone R. Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention. Endocr Rev (2023) 44:737–51. doi: 10.1210/endrev/bnad007</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnad007</ArticleId><ArticleId IdType="pubmed">36884282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruun SW, Josefsen K, Tanassi JT, Marek A, Pedersen MH, Sidenius U, et al. . Large gliadin peptides detected in the pancreas of NOD and healthy mice following oral administration. J Diabetes Res (2016) 2016:2424306. doi: 10.1155/2016/2424306</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2424306</ArticleId><ArticleId IdType="pmc">PMC5067331</ArticleId><ArticleId IdType="pubmed">27795959</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, et al. . Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia (2006) 49:2824–7. doi: 10.1007/s00125-006-0465-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-006-0465-3</ArticleId><ArticleId IdType="pubmed">17028899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanninen A, Toivonen R, Poysti S, Belzer C, Plovier H, Ouwerkerk JP, et al. . Akkermansia muciniphila induces gut microbiota remodelling and controls islet autoimmunity in NOD mice. Gut (2018) 67:1445–53. doi: 10.1136/gutjnl-2017-314508</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2017-314508</ArticleId><ArticleId IdType="pubmed">29269438</ArticleId></ArticleIdList></Reference><Reference><Citation>Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buschard K. Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab Res Rev (1999) 15:323–7. doi: 10.1002/(sici)1520-7560(199909/10)15:5&lt;323::aid-dmrr53&gt;3.0.co;2-p</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1520-7560(199909/10)15:5&lt;323::aid-dmrr53&gt;3.0.co;2-p</ArticleId><ArticleId IdType="pubmed">10585617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastore MR, Bazzigaluppi E, Belloni C, Arcovio C, Bonifacio E, Bosi E. Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes. J Clin Endocrinol Metab (2003) 88:162–5. doi: 10.1210/jc.2002-021177</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2002-021177</ArticleId><ArticleId IdType="pubmed">12519846</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabetes Stud (2004) 1:39–41. doi: 10.1900/RDS.2004.1.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1900/RDS.2004.1.39</ArticleId><ArticleId IdType="pmc">PMC1783529</ArticleId><ArticleId IdType="pubmed">17491663</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson J, Sildorf SM, Pipper CB, Kyvsgaard JN, Bojstrup J, Pociot FM, et al. . Potential beneficial effects of a gluten-free diet in newly diagnosed children with type 1 diabetes: a pilot study. Springerplus (2016) 5:994. doi: 10.1186/s40064-016-2641-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-016-2641-3</ArticleId><ArticleId IdType="pmc">PMC4936999</ArticleId><ArticleId IdType="pubmed">27398272</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdellatif AM, Sarvetnick NE. Current understanding of the role of gut dysbiosis in type 1 diabetes. J Diabetes (2019) 11:632–44. doi: 10.1111/1753-0407.12915</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1753-0407.12915</ArticleId><ArticleId IdType="pubmed">30864231</ArticleId></ArticleIdList></Reference><Reference><Citation>Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun (2018) 9:3294. doi: 10.1038/s41467-018-05470-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-05470-4</ArticleId><ArticleId IdType="pmc">PMC6098093</ArticleId><ArticleId IdType="pubmed">30120222</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, et al. . Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes (2020) 12:1–24. doi: 10.1080/19490976.2020.1788899</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2020.1788899</ArticleId><ArticleId IdType="pmc">PMC7524359</ArticleId><ArticleId IdType="pubmed">32783770</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteleone I, Rizzo A, Sarra M, Sica G, Sileri P, Biancone L, et al. . Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology (2011) 141:237–248, 248 e231. doi: 10.1053/j.gastro.2011.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.04.007</ArticleId><ArticleId IdType="pubmed">21600206</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Genoni A, Puggioni A, Campani D, Richardson SJ, Flaxman CS, et al. . Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study. Diabetologia (2022) 65:2108–20. doi: 10.1007/s00125-022-05779-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05779-2</ArticleId><ArticleId IdType="pmc">PMC9630231</ArticleId><ArticleId IdType="pubmed">35953727</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L, Edwin B, Buanes T, Frisk G, Skog O, Anagandula M, et al. . Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes (2015) 64:1682–7. doi: 10.2337/db14-1370</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzilli P, Bosi E, Cirkel D, Harris J, Leech N, Tinahones FJ, et al. . Randomized 52-week phase 2 trial of albiglutide versus placebo in adult patients with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab (2020) 105:e2192–e2206. doi: 10.1210/clinem/dgaa149</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa149</ArticleId><ArticleId IdType="pubmed">32219329</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold KC, Reynolds J, Dziura J, Baidal D, Gaglia J, Gitelman SE, et al. . Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diabetes Obes Metab (2020) 22:2045–54. doi: 10.1111/dom.14121</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14121</ArticleId><ArticleId IdType="pmc">PMC8009602</ArticleId><ArticleId IdType="pubmed">32573927</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards K, Li X, Lingvay I. Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study. J Clin Endocrinol Metab (2023) 108:920–30. doi: 10.1210/clinem/dgac618</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac618</ArticleId><ArticleId IdType="pubmed">36268825</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod KH, Mason L, Marino E. Transplantation of fecal microbiota shaped by diet. Bio Protoc (2018) 8:e2683. doi: 10.21769/BioProtoc.2683</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.2683</ArticleId><ArticleId IdType="pmc">PMC8203959</ArticleId><ArticleId IdType="pubmed">34179235</ArticleId></ArticleIdList></Reference><Reference><Citation>Funsten MC, Yurkovetskiy LA, Kuznetsov A, Reiman D, Hansen CHF, Senter KI, et al. . Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetes. Cell Host Microbe (2023) 31:213–227 e219. doi: 10.1016/j.chom.2022.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.12.009</ArticleId><ArticleId IdType="pmc">PMC9911364</ArticleId><ArticleId IdType="pubmed">36603588</ArticleId></ArticleIdList></Reference><Reference><Citation>Tlaskalova-Hogenova H, Stepankova R, Tuckova L, Farre MA, Funda DP, Verdu EF, et al. . Autoimmunity, immunodeficiency and mucosal infections: chronic intestinal inflammation as a sensitive indicator of immunoregulatory defects in response to normal luminal microflora. Folia Microbiol (Praha) (1998) 43:545–50. doi: 10.1007/BF02820817</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02820817</ArticleId><ArticleId IdType="pubmed">9821323</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>